Cleared Special

K183306 - GLUCOCARD W onyx Blood Glucose Monitori...

K183306 is the FDA 510(k) clearance for GLUCOCARD W onyx Blood Glucose Monitori... by Arkray Factory, Inc.. It is a Class 2 Chemistry device (product code NBW) cleared through the Special 510(k) pathway after a 133-day FDA review.

K183306 · Arkray Factory, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2019
Decision
133d
Days
Class 2
Risk

K183306 is an FDA 510(k) clearance for the GLUCOCARD® W onyx Blood Glucose Monitoring System. Classified as System, Test, Blood Glucose, Over The Counter (product code NBW), Class II - Special Controls.

Submitted by Arkray Factory, Inc. (Kamigyo-Ku, JP). The FDA issued a Cleared decision on April 10, 2019 after a review of 133 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Arkray Factory, Inc. devices

Submission Details

510(k) Number K183306 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 28, 2018
Decision Date April 10, 2019
Days to Decision 133 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
45d slower than avg
Panel avg: 88d · This submission: 133d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code NBW System, Test, Blood Glucose, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Consultant

Arkra Y America, Inc.
Dhwani Thakkar

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - NBW System, Test, Blood Glucose, Over The Counter

All 235
Devices cleared under the same product code (NBW) and FDA review panel - the closest regulatory comparables to K183306.
TD-4183 Blood Glucose Monitoring System
K190579 · Taidoc Technology Corporation · Jun 2019
Rightest Blood Glucose Monitoring System GM700S, Rightest Blood Glucose Monitoring System GM700SB
K190564 · Bionime Corporation · Jun 2019
GlucoLeader Enhance Blood Glucose Monitoring System
K182428 · Hmd Biomedical, Inc. · May 2019
iHealth Wireless Smart Gluco-Monitoring System (iHealth Gluco+)
K181070 · Andon Health Co, Ltd. · Feb 2019
VivaChek Ino Smart Blood Glucose Monitoring System, VivaChek Ino Sync Blood Glucose Monitoring System, VivaChek Ino Sound Blood Glucose Monitoring System, VivaChek Ino Plus Blood Glucose Monitoring System, VivaChek Ino Sound Simple Blood Glucose Monitoring System, VivaChek Ino Sound Bright Blood Glucose Monitoring System
K173140 · Vivachek Laboratories, Inc. · Dec 2018
Accu-Chek Guide Me Blood Glucose Monitoring System
K181131 · Roche Diabetes Care · Dec 2018